RPAM
Rhenman & Partners Asset Management Portfolio holdings
AUM
$791M
This Quarter Return
+7.38%
1 Year Return
+12.81%
3 Year Return
+98.32%
5 Year Return
+175.58%
10 Year Return
+579.5%
AUM
$1.47B
AUM Growth
+$39M
(+2.7%)
Cap. Flow
-$26.1M
Cap. Flow
% of AUM
-1.77%
Top 10 Holdings %
Top 10 Hldgs %
26.19%
Holding
101
New
9
Increased
29
Reduced
33
Closed
7
Top Buys
| 1 |
Biogen
BIIB
|
$24.4M |
| 2 |
Veeva Systems
VEEV
|
$19.9M |
| 3 |
Pfizer
PFE
|
$19.6M |
| 4 |
INOV
Inovalon Holdings, Inc. Class A Common Stock
INOV
|
$13.1M |
| 5 |
SGEN
Seagen Inc. Common Stock
SGEN
|
$12.3M |
Top Sells
| 1 |
Johnson & Johnson
JNJ
|
$41.2M |
| 2 |
Bristol-Myers Squibb
BMY
|
$13.4M |
| 3 |
NovoCure
NVCR
|
$13.3M |
| 4 |
LivaNova
LIVN
|
$12.2M |
| 5 |
Eli Lilly
LLY
|
$11.8M |
Sector Composition
| 1 | Healthcare | 94.98% |
| 2 | Industrials | 1.94% |
| 3 | Technology | 0% |